Cite
HARVARD Citation
Ahmadieh, H. et al. (2019). Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial. British journal of ophthalmology. 103 (7), pp. 922-927. [Online].